Csenge Advisory Group’s PharmaCyte Biotech PMCB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-200,104
Closed -$480K 645
2022
Q3
$480K Buy
+200,104
New +$480K 0.04% 349